Heredity and DNA methylation in colorectal cancer [4]

Gut

Volumn 56, Issue 1, 2007, Pages 154-155

  Jass, J R ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; PROTEIN MLH1;

COLORECTAL CANCER; CPG ISLAND; DISEASE COURSE; DNA METHYLATION; FAMILIAL CANCER; FAMILY; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENOME IMPRINTING; HEREDITY; HUMAN; LETTER; MUTATIONAL ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT;

CARRIER PROTEINS; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; HEREDITY; HUMANS; MICROSATELLITE INSTABILITY; NEOPLASM PROTEINS; NUCLEAR PROTEINS;

EID: 33845990608     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (15)

1. Frazier ML, Xi L, Zong J, et al. Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer. Cancer Res 2003;63:4805-8.
2. Ward RL, Williams R, Law M, et al. The CpG island methylator phenotype is not associated with a personal or family history of cancer. Cancer Res 2004;64:7618-21.
3. Suter CM, Martin DIK, Ward RL. Germline epimutation of MLH1 in individuals with multiple cancers. Nat Genet 2004;36:497-501.
4. Lindor NM, Rabe K, Petersen GM, et al. Lower cancer incidence in Amsterdam-1 criteria families without mismatch repair deficiency. Familial colorectal cancer type X. JAMA 2005;293:1979-85.
5. Samowitz WS, Albertsen H, Herrick J, et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 2005;129:837-45.
6. Weisenberger DJ, Siegmund KD, Campan M, et al. A distinct CpG island methylator phenotype in human colorectal cancer is the underlying cause of sporadic mismatch repair deficiency and is tightly associated with BRAF mutation. Nat Genet 2006;38:787-93.
7. Samowitz WS, Sweeney C, Herrick J, et al. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res 2005;65:6063-9.
8. Young J, Barker MA, Simms LA, et al. BRAF mutation and variable levels of microsatellite instability characterize a syndrome of familial colorectal cancer. Clin Gastroenterol Hepatol 2005;3:254-03.
9. Jass JR, Cottier DS, Pokos V, et al. Mixed epithelial polyps in association with hereditary non-polyposis colorectal cancer providing an alternative pathway of cancer histogenesis. Pathology 1997;29:28-33.
10. Cui H, Cruz-Correa M, Giardiello FM, et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 2003;299:1753-5.
11. Sasaki J-I, Konishi F, Kawamura YJ, et al. Clinicopathological characteristics of colorectal cancers with loss of imprinting of insulin-like growth factor 2. Int J Cancer 2006;119:80-3.
12. Nakagawa H, Chadwick RB, Peltomaki P, et al. Loss of imprinting of the insulin-like growth factor II gene occurs by bi-allelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc Natl Acad Sci USA 2001;98:591-6.
13. Gazzoli I, Loda M, Garber J, et al. A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the hMLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor. Cancer Res 2002;62:3925-8.
14. Miyakura Y, Sugano K, Akasu T, et al. Extensive but hemiallelic methylation of the hMLH1 promoter region in early-onset sporadic colon cancers with microsatellite instability. Clin Gastroenterol Hepatol 2004;2:147-56.
15. Hitchins M, Williams R, Cheong K, et al. MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer. Gastroenterology 2005;129:1392-9.